San Francisco, CA, United States of America

Michael J Schmitt


 

Average Co-Inventor Count = 12.0

ph-index = 6

Forward Citations = 159(Granted Patents)


Location History:

  • San Francisco, CA (US) (2008 - 2010)
  • Oakland, CA (US) (2009 - 2011)
  • McLean, VA (US) (2016)

Company Filing History:


Years Active: 2008-2016

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Michael J. Schmitt: Innovator in Cancer Treatment and Metabolic Disorders

Introduction

Michael J. Schmitt is a prominent inventor based in San Francisco, CA, with an impressive portfolio of 11 patents. His work primarily focuses on the development of pharmaceutical compounds that target critical health issues such as cancer and metabolic disorders. Schmitt's innovative contributions have the potential to significantly impact the medical field and improve patient outcomes.

Latest Patents

Among his latest patents, Schmitt has developed “Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer.” This invention provides a variety of MDM2 inhibitor compounds that are particularly useful as therapeutic agents for treating various forms of cancers. Additionally, his patent titled “Heterocyclic GPR40 modulators” focuses on compounds designed to assist in the treatment of metabolic disorders, including type II diabetes. These compounds demonstrate significant promise in the development of medicaments that help manage and treat these critical health conditions.

Career Highlights

Michael J. Schmitt has established himself as a leading figure in pharmaceutical research and development at Amgen Inc. His tenure at the company highlights his dedication to advancing healthcare solutions through innovative toxicology and pharmacology.

Collaborations

Throughout his career, Schmitt has collaborated with talented researchers, including his colleagues Julio Cesar Medina and Jiwen Liu. These partnerships have fostered a collaborative environment where groundbreaking research and innovative ideas can flourish, driving significant advancements in therapeutic agents.

Conclusion

Michael J. Schmitt continues to make strides in the realm of innovation, offering new solutions for challenging medical conditions. His inventions not only exemplify his expertise but also reflect a commitment to improving health outcomes for patients worldwide. With an unwavering drive for discovery, Schmitt's work remains vital in the quest for effective treatments in cancer and metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…